A Single Arm Phase II Study of Palbociclib in Combination with Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-016

Learn more:

• https://clinicaltrials.gov/study/NCT02668666
• See Study Locations on Big Ten CRC Website